Novo Nordisk's stock price has experienced a significant decline, with some outlets reporting a 52% or 64% drop over a certain period. The company has released a forecast that has been described as "brutal" and warned of a potential sales hit, causing its shares to tumble. There are varying opinions on the stock's potential, with some considering it a potential buy and others warning that it may be a trap.